Scopus Asset Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-150,000
Closed -$6.12M 158
2022
Q1
$6.12M Buy
150,000
+50,000
+50% +$2.15M 0.15% 175
2021
Q4
$4.79M Buy
+100,000
New +$4.49M 0.1% 200
2019
Q1
Sell
-100,000
Closed -$1.51M 141
2018
Q4
$1.51M Sell
100,000
-200,000
-67% -$5.17M 0.1% 106
2018
Q3
$11.8M Buy
300,000
+100,000
+50% +$4.51M 0.16% 140
2018
Q2
$9.84M Buy
200,000
+100,000
+100% +$5.67M 0.09% 212
2018
Q1
$5.98M Buy
+100,000
New +$6.67M 0.06% 232

Other funds holding ADNT

Scopus Asset Management's ADNT Position: Q3 2022 in Review

Scopus Asset Management sold out of Adient (ADNT) in Q3 2022, closing a stake of 60,000 shares — an estimated $1.78M sold.

Scopus Asset Management first reported a position in ADNT in Q4 2020 and held it in 5 quarters. The position peaked at $9.26M in Q4 2020. 247 funds tracked by Wall St. Rank hold ADNT as of Q3 2022.

  • Scopus Asset Management reported no remaining Adient position as of Q3 2022 after selling out during the quarter.
  • Scopus Asset Management sold 60,000 Adient shares in Q3 2022, an estimated $1.78M.
  • Scopus Asset Management first reported a position in Adient in Q4 2020 and held it in 5 quarters.
  • Scopus Asset Management's Adient position peaked at $9.26M in Q4 2020.
  • 247 funds tracked by Wall St. Rank held Adient as of Q3 2022.

Based on Scopus Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.